Supplementary Movie S4 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates

Supplementary Movie S4 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates

<p>Supplementary Movie S4. IVIM in vivo imaging was used to observe that heparin promoted the infiltration of transferred CD8+ T cells into Panc02 orthotopic tumors. The video corresponded to the experiment shown in Figure 6B. Representative images at 48h of CD8+ T adoptive transfer group were...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Fang Wei (15057172) (author)
Weitere Verfasser:	Yuling Su (15057175) (author), Yibo Quan (15057178) (author), Xiaojia Li (15057181) (author), Qi Zou (15057184) (author), Liuxi Zhang (15057187) (author), Shu Li (15057190) (author), Mengmeng Jiang (15057193) (author), Guohuan Lin (15057196) (author), Ping Liang (15057199) (author), Jie He (15057202) (author), Keping Xie (15057205) (author)
Veröffentlicht:	2025
Schlagworte:	Cancer Tumor Biology Therapeutic Research and Development Angiogenesis Angiogenesis inhibitors & stimulators Drug Mechanisms Cellular responses to anticancer drugs Gastrointestinal Cancers Pancreatic cancer Translational Research
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Supplementary Movie S1 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
von: Fang Wei (15057172)
Veröffentlicht: (2025)

Supplementary Movie S2 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
von: Fang Wei (15057172)
Veröffentlicht: (2025)

Supplementary Movie S3 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
von: Fang Wei (15057172)
Veröffentlicht: (2025)

Supplementary Movie S5 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
von: Fang Wei (15057172)
Veröffentlicht: (2025)

Supplementary Movie S6 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
von: Fang Wei (15057172)
Veröffentlicht: (2025)

Supplementary Movie S7 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
von: Fang Wei (15057172)
Veröffentlicht: (2025)

Supplementary Movie S8 from Anticoagulants Enhance Molecular and Cellular Immunotherapy of Cancer by Improving Tumor Microcirculation Structure and Function and Redistributing Tumor Infiltrates
von: Fang Wei (15057172)
Veröffentlicht: (2025)

Supplementary Table 1 from <i>N<sup>6</sup></i>-Methyladenosine Promotes Translation of VEGFA to Accelerate Angiogenesis in Lung Cancer
von: Haisheng Zhang (16436982)
Veröffentlicht: (2025)

Suppl. Figure 1 from Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis
von: Teresa González-Muñoz (16797866)
Veröffentlicht: (2025)

Suppl. Figure 2 from Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis
von: Teresa González-Muñoz (16797866)
Veröffentlicht: (2025)

Suppl. Figure 3 from Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis
von: Teresa González-Muñoz (16797866)
Veröffentlicht: (2025)

Suppl. Figure 4 from Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis
von: Teresa González-Muñoz (16797866)
Veröffentlicht: (2025)

Suppl. Figure 5 from Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis
von: Teresa González-Muñoz (16797866)
Veröffentlicht: (2025)

Suppl. Figure 6 from Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis
von: Teresa González-Muñoz (16797866)
Veröffentlicht: (2025)

Supplementary Data 1 from Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis
von: Teresa González-Muñoz (16797866)
Veröffentlicht: (2025)

Supplementary Data 2 from Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis
von: Teresa González-Muñoz (16797866)
Veröffentlicht: (2025)

Supplementary Data 3 from Endoglin, a Novel Biomarker and Therapeutical Target to Prevent Malignant Peripheral Nerve Sheath Tumor Growth and Metastasis
von: Teresa González-Muñoz (16797866)
Veröffentlicht: (2025)

Figure 1 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
von: Isabel Quiros-Gonzalez (14952835)
Veröffentlicht: (2025)

Figure 2 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
von: Isabel Quiros-Gonzalez (14952835)
Veröffentlicht: (2025)

Figure 3 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
von: Isabel Quiros-Gonzalez (14952835)
Veröffentlicht: (2025)

Figure 4 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
von: Isabel Quiros-Gonzalez (14952835)
Veröffentlicht: (2025)

Figure 5 from Photoacoustic Tomography Detects Response and Resistance to Bevacizumab in Breast Cancer Mouse Models
von: Isabel Quiros-Gonzalez (14952835)
Veröffentlicht: (2025)

Supplementary file 3: Supplementary Tables. from circFNDC3B Accelerates Vasculature Formation and Metastasis in Oral Squamous Cell Carcinoma
von: Xiang Li (15386727)
Veröffentlicht: (2025)

Supplementary file 1_Toxicity evaluation of laser-synthesized pro-angiogenic carbon monoxide-rich gold nanoparticles in vitro and in vivo.docx
von: Thais Braga Gomes Araujo (22686905)
Veröffentlicht: (2025)

Supplementary Table S1 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
von: Michael D. Nyquist (16918265)
Veröffentlicht: (2025)

Supplemental Figures 1-4 from Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex
von: Michael D. Nyquist (16918265)
Veröffentlicht: (2025)

Supplementary Table S1 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
von: Nicole A. Traphagen (16677391)
Veröffentlicht: (2025)

Supplementary Table S2 from Estrogen Therapy Induces Receptor-Dependent DNA Damage Enhanced by PARP Inhibition in ER+ Breast Cancer
von: Nicole A. Traphagen (16677391)
Veröffentlicht: (2025)

Supplementary Movie S1 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
von: Jesse C. Patterson (14962862)
Veröffentlicht: (2025)

Supplementary Movie S2 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
von: Jesse C. Patterson (14962862)
Veröffentlicht: (2025)

Supplementary Movie S3 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
von: Jesse C. Patterson (14962862)
Veröffentlicht: (2025)

Supplementary Movie S4 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
von: Jesse C. Patterson (14962862)
Veröffentlicht: (2025)

Supplementary Movie S5 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
von: Jesse C. Patterson (14962862)
Veröffentlicht: (2025)

Supplementary Movie S6 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
von: Jesse C. Patterson (14962862)
Veröffentlicht: (2025)

Supplementary Movie S7 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
von: Jesse C. Patterson (14962862)
Veröffentlicht: (2025)

Supplementary Movie S8 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
von: Jesse C. Patterson (14962862)
Veröffentlicht: (2025)

Supplementary Movie S9 from Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling
von: Jesse C. Patterson (14962862)
Veröffentlicht: (2025)

Supplementary Data from Pharmacological Targeting of Androgen Receptor Elicits Context-Specific Effects in Estrogen Receptor–Positive Breast Cancer
von: Lixuan Wei (14962431)
Veröffentlicht: (2025)

Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
von: Evangeline R. Jackson (15558808)
Veröffentlicht: (2025)

Supplementary Data 1 from Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltration
von: Gregory L. Beatty (15087193)
Veröffentlicht: (2025)

Cannot write session to /tmp/vufind_sessions/sess_3qp19bpcsrejgcekh12ie35amf